- Home
- OCGN vs REE Comparison
OCGN vs REE Comparison
Compare OCGN & REE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- REE
- Stock Information
- Founded
- OCGN 2013
- REE 2011
- Country
- OCGN United States
- REE Israel
- Employees
- OCGN N/A
- REE N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- REE Auto Manufacturing
- Sector
- OCGN Health Care
- REE Consumer Discretionary
- Exchange
- OCGN Nasdaq
- REE Nasdaq
- Market Cap
- OCGN 246.8M
- REE 201.6M
- IPO Year
- OCGN N/A
- REE N/A
- Fundamental
- Price
- OCGN $0.89
- REE $9.96
- Analyst Decision
- OCGN Strong Buy
- REE Buy
- Analyst Count
- OCGN 3
- REE 3
- Target Price
- OCGN $5.67
- REE $11.00
- AVG Volume (30 Days)
- OCGN 6.1M
- REE 124.7K
- Earning Date
- OCGN 11-08-2024
- REE 12-17-2024
- Dividend Yield
- OCGN N/A
- REE N/A
- EPS Growth
- OCGN N/A
- REE N/A
- EPS
- OCGN N/A
- REE N/A
- Revenue
- OCGN $4,700,000.00
- REE $626,000.00
- Revenue This Year
- OCGN N/A
- REE N/A
- Revenue Next Year
- OCGN N/A
- REE $50,620.25
- P/E Ratio
- OCGN N/A
- REE N/A
- Revenue Growth
- OCGN N/A
- REE N/A
- 52 Week Low
- OCGN $0.49
- REE $2.91
- 52 Week High
- OCGN $2.11
- REE $11.72
- Technical
- Relative Strength Index (RSI)
- OCGN 54.92
- REE 57.00
- Support Level
- OCGN $0.79
- REE $8.61
- Resistance Level
- OCGN $0.88
- REE $11.63
- Average True Range (ATR)
- OCGN 0.08
- REE 1.12
- MACD
- OCGN 0.01
- REE -0.05
- Stochastic Oscillator
- OCGN 65.97
- REE 51.87
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is developing REEcorner technology which packs critical vehicle components into a single compact module positioned between the chassis and the wheel as well as building commercial Electric Vehicles (EV) leveraging REEcorner technology. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.